Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs Remitly Global Inc (RELY) Price & Performance

Medpace Holdings IncTrade
Remitly Global IncTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs Remitly Global Inc — how do they compare? Medpace Holdings Inc trades at $597.39 (market cap $16.90B), while Remitly Global Inc trades at $24.38 (market cap $4.97B). The key difference: Medpace Holdings Inc is far larger — about 3.4× Remitly Global Inc's market cap. Which is the better fit depends on your goals.

MEDPRELY
Market Cap
$16.90B$4.97B
Sector
TechnologyTechnology
52-Week High
$620.59$25.93
52-Week Low
$393.42$12.20
Enterprise Value
$16.52B$4.33B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.

MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.

Remitly Global Inc

RELY trades at $24.25, up 4.8% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 results, with revenue of $495 million and adjusted EBITDA of $114.7 million, beating estimates. Revenue growth accelerated to 20% year-over-year, and net income turned positive in 2025, reaching $67.93 million. Recent initiatives include the launch of the Global Card and expansion in the UAE market.

The outlook is positive, driven by market share gains, new product launches, and improving profitability. Risks include competitive pressures in remittances and execution of growth initiatives. Analyst consensus is strongly bullish with a $31.00 price target, implying significant upside from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About Remitly Global Inc

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Read more on RELY